We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-15.72%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$4.46B
AUM Growth
-$6B
Cap. Flow
-$4.51B
Cap. Flow %
-101.07%
Top 10 Hldgs %
21.21%
Holding
7,134
New
733
Increased
2,939
Reduced
2,324
Closed
739

Top Buys

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$41.1M
2
IWD icon
iShares Russell 1000 Value ETF
IWD
+$25.3M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$18.4M
4
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$15.7M
5
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$15.4M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$372M
3
AMZN icon
Amazon
AMZN
+$192M
4
TSLA icon
Tesla
TSLA
+$121M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$111M

Sector Composition

Rank Sector Weight
1 Technology 22.54%
2 Healthcare 10.8%
3 Consumer Discretionary 9.19%
4 Financials 8.28%
5 Communication Services 7.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OSBC icon
3451
Old Second Bancorp
OSBC
$1.31B
$28K ﹤0.01%
2,108
-8,808
-81% -$126K
OVBC icon
3452
Ohio Valley Banc Corp
OVBC
$218M
$28K ﹤0.01%
+909
New +$27.5K
RLMD icon
3453
Relmada Therapeutics
RLMD
$507M
$28K ﹤0.01%
1,469
+1,261
+606% +$27.5K
RMR icon
3454
The RMR Group
RMR
$346M
$28K ﹤0.01%
980
+795
+430% +$22.9K
SJT
3455
San Juan Basin Royalty Trust
SJT
$129M
$28K ﹤0.01%
+3,188
New +$34.6K
TCRX icon
3456
TScan Therapeutics
TCRX
$52.3M
$28K ﹤0.01%
9,027
+1,138
+14% +$3.11K
TILE icon
3457
Interface
TILE
$2.24B
$28K ﹤0.01%
2,201
-1,279
-37% -$17K
WMK icon
3458
Weis Markets
WMK
$1.77B
$28K ﹤0.01%
373
-6,010
-94% -$466K
ZVRA icon
3459
Zevra Therapeutics
ZVRA
$664M
$28K ﹤0.01%
6,274
-21,969
-78% -$100K
BIG
3460
DELISTED
Big Lots, Inc.
BIG
$28K ﹤0.01%
1,336
-6,614
-83% -$195K
OSG
3461
DELISTED
Overseas Shipholding Group Inc.
OSG
$28K ﹤0.01%
13,865
-3,339
-19% -$7.16K
EIGR
3462
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$28K ﹤0.01%
149
-81
-35% -$16.3K
OBSV
3463
DELISTED
ObsEva SA Ordinary Shares
OBSV
$28K ﹤0.01%
17,457
+16,453
+1,639% +$27.2K
ZY
3464
DELISTED
Zymergen Inc. Common Stock
ZY
$28K ﹤0.01%
22,532
+13,236
+142% +$22.2K
AQB icon
3465
AquaBounty Technologies
AQB
$7.72M
$27K ﹤0.01%
776
+549
+242% +$16.8K
BLDP
3466
Ballard Power Systems
BLDP
$790M
$27K ﹤0.01%
4,249
-31,275
-88% -$250K
CDXS icon
3467
Codexis
CDXS
$175M
$27K ﹤0.01%
2,574
-996
-28% -$12.5K
COGT icon
3468
Cogent Biosciences
COGT
$6.47B
$27K ﹤0.01%
3,026
+603
+25% +$4.12K
FINX icon
3469
Global X FinTech ETF
FINX
$173M
$27K ﹤0.01%
1,273
+1,113
+696% +$28.5K
IESC icon
3470
IES Holdings
IESC
$14.9B
$27K ﹤0.01%
888
+531
+149% +$17.1K
ILF icon
3471
iShares Latin America 40 ETF
ILF
$3.69B
$27K ﹤0.01%
1,207
-2,193
-65% -$58.4K
IPSC icon
3472
Century Therapeutics
IPSC
$349M
$27K ﹤0.01%
3,253
+2,459
+310% +$24.1K
JBI icon
3473
Janus International
JBI
$686M
$27K ﹤0.01%
2,964
+1,047
+55% +$10.2K
LTRX icon
3474
Lantronix
LTRX
$272M
$27K ﹤0.01%
4,990
-7,157
-59% -$41.3K
MBIN icon
3475
Merchants Bancorp
MBIN
$2.54B
$27K ﹤0.01%
1,195
-4,686
-80% -$114K
137 138
139
140 141

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2022 Portfolio in Review

As of Q2 2022, Tower Research Capital (TRC) held 7,134 positions worth $4.46B, down 57% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.51B in Q2 2022, closing 739 positions and reducing 2,324 holdings. Its most notable exit was iShares MSCI USA Value Factor ETF, an estimated $13.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 Value ETF worth $23.4M.

  • Tower Research Capital (TRC)'s largest Q2 2022 buy was iShares Russell 1000 Value ETF: 161,690 shares worth $23.4M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q2 2022, an estimated $41.1M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2022 reduction was Apple, cutting an estimated $411M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Value Factor ETF in Q2 2022, selling an estimated $13.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 21% of its $4.46B portfolio in Q2 2022.
  • Tower Research Capital (TRC) opened 733 new positions and closed 739 in Q2 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 57% quarter-over-quarter to $4.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.